| - | A Nanoplatform of Protein Cage as Molecular Imaging Probe | Choi Seung hye; Choi Kyung Mi; Choi, Kuiwon; Kwon, Ick Chan; Ahn Hyung Jun |
| - | A platform-technology for systemic delivery of siRNA to tumors using rolling circle transcription and its applications for optical imaging probes | Ahn Hyung Jun |
| - | A platform-technology for systemic delivery of siRNA to tumors using rolling circle transcription and its applications for optical imaging probes | MIHUE JANG; Kim Jong Hwan; Ahn Hyung Jun |
| - | A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy | Ahn Hyung Jun |
| - | A RNA nanotechnology platform for a two-in-one siRNA delivery and its application in synergistic RNAi therapy | Ahn Hyung Jun |
| 2019-04-19 | A T7 autogene-based hybrid mRNA/DNA system for long-term shRNA expression in cytoplasm without inefficient nuclear entry | Ahn Hyung Jun |
| 2019-07 | Alternative approaches for overcoming transient silencing effects of RNAi or drug resistance in chemoresistant cancers | Ahn Hyung Jun |
| - | Anti-cancer immune therapy of pancreatic cancer by blocking PD-1/ PD-L1 immune check point pathway | Phuong Ngo; Kwak,Seo-Young; Ahn Hyung Jun |
| 2019-06 | Antitumor effects of retargeted AAV2 virus on ovarian cancer in vivo | Ahn Hyung Jun; sungjin LEE |
| 2022-05 | Antitumor effects of retargeted AAV2 virus on ovarian cancer in vivo | sungjin LEE; Ahn Hyung Jun |
| - | Applications of siRNA prodrug in cancer research | Ahn Hyung Jun |
| - | Chimeric Capsid Protein as a Nanocarrier for siRNA Delivery: Stability and Cellular Uptake of Encapsulated siRNA | Choi Kyung Mi; Choi Seung Hye; Hyesung Jeon; In-San Kim; Ahn Hyung Jun |
| 2020-07 | Cytoplasmic expression of EGFR shRNA using modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects | sharmin seraj; Ahn Hyung Jun |
| - | Design and Application of Rolling Circle Amplification for a Tumor-Specific Drug Carrier | Kim Jong Hwan; MIHUE JANG; Kim Young Je; Ahn Hyung Jun |
| 2015-04 | Design of a platform-technology for systemic delivery of siRNA to tumors using rolling circle transcription | Ahn Hyung Jun |
| - | DNA Nanoparticles for a Tumor-Specific Anticancer Drug Carrier; Application of Rolling Circle Amplification | Ahn Hyung Jun |
| - | Enhanced cancer therapy by delivering self-assembled RNAi nanoparticles against multiple targets and chemotherapeutic agent to overcome chemoresistance | MIHUE JANG; Ahn Hyung Jun |
| - | Genetically-modified Tomato aspermy virus 2b protein as a
tumor-targeting siRNA delivery carrier | Kim Jong Hwan; Eun Young Park; Mihue JANG; Ahn Hyung Jun |
| 2020-07 | KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors | 이진주; Ahn Hyung Jun |
| 2019-04-18 | PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery carrier for ovarian cancer therapy | Ahn Hyung Jun |
| - | PLGA nanoparticles co-delivering BCL2 and MDR1 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer | Chitra Risnayanti; Ahn Hyung Jun |
| - | Protein Cages Provide a Platform of Cell-Permeable and Biocompatible Imaging Probe in Living Cells | Choi Seung hye; Choi, Kuiwon; Kwon, Ick Chan; Kwang Yeon Hwang; Ahn Hyung Jun |
| - | Protein cages provide a platform of cell-permeable and biocompatible imaging probe in living cells | Choi Seung hye; Choi, Kuiwon; Kwon, Ick Chan; Kwang Yeon Hwang; Ahn Hyung Jun |
| 2017-05 | Rational design and application of RNA nanoparticles for RNAi-based cancer therapy | Ahn Hyung Jun |
| - | Rational design and applications of RNA nanoparticles for RNAi-based cancer therapy | Ahn Hyung Jun |
| - | Rational Design and Applications of RNAi Delivery Carrier for Cancer Therapy | Ahn Hyung Jun |
| 2019-04-18 | Retargeting and antitumor effects of adeno-associated virus on OVCAR3 ovarian cancer in vivo | Ahn Hyung Jun |
| - | RNA nanoparticles as a two-in-one siRNA delivery carrier synergistically suppress drug-resistance cancer via combination therapy with doxorubicin | Ahn Hyung Jun |
| - | RNA prodrug과 Patient-Derived Xenograft (PDX) 마우스 모델을 이용한 난치성 난소암의 맞춤형 유전자 치료 기술 개발 | Ahn Hyung Jun |
| 2021-04-22 | Systemic Delivery of CRISPR/Cas9 to Hepatic Tumors Using Altered Tropism of Lentiviral Vector in Cancer Therapy | Sungjin Lee; Ahn Hyung Jun |
